115
Participants
Start Date
December 1, 2022
Primary Completion Date
December 30, 2022
Study Completion Date
January 1, 2023
Dexmedetomidine
Dexmedetomidine is the most popular adjuvant to anesthesia. Groups was grouped according to different preadministered doses of dexmedetomidine. This allows a more comprehensive assessment of remimazolam under different use. Three groups were set separately, and Group A, Group B, and Group C correspond to 0,0.5, and 1 μg/kg at first 10 mins , respectively.
Remimazolam tosilate
Remimazolam tosilate has a short clinical time and a lack of combination with dexmedetomidine for dual-lumen endotracheal intubation. The optimal use dose of Remimazolam tosilate was explored separately from different dexmedetomidine doses.
Shanghai Pulmonary Hospital, Shanghai
Shiyou Wei
OTHER